Optimisation of the Covid-19 vaccine strategy: The case of Pfizer BioNTech vaccine in France

Olivier Péton ()
Additional contact information
Olivier Péton: LS2N - équipe SLP - Systèmes Logistiques et de Production - LS2N - Laboratoire des Sciences du Numérique de Nantes - UN UFR ST - Université de Nantes - UFR des Sciences et des Techniques - UN - Université de Nantes - ECN - École Centrale de Nantes - CNRS - Centre National de la Recherche Scientifique - IMT Atlantique - IMT Atlantique - IMT - Institut Mines-Télécom [Paris], IMT Atlantique - DAPI - Département Automatique, Productique et Informatique - IMT Atlantique - IMT Atlantique - IMT - Institut Mines-Télécom [Paris]

Post-Print from HAL

Date: 2021-09-29
References: Add references at CitEc
Citations:

Published in PROLOG 2021, Sep 2021, Nantes, France

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-03369540

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().